Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.
Bissonnette R, Papp K, Poulin Y, Lauzon G, Aspeslet L, Huizinga R, Mayo P, Foster RT, Yatscoff RW, Maksymowych WP; ISA247 Psoriasis Study Group. Bissonnette R, et al. Among authors: yatscoff rw. J Am Acad Dermatol. 2006 Mar;54(3):472-8. doi: 10.1016/j.jaad.2005.10.061. Epub 2006 Jan 23. J Am Acad Dermatol. 2006. PMID: 16488299 Clinical Trial.
The portal immunosuppressive storm: relevance to islet transplantation?
Shapiro AM, Gallant HL, Hao EG, Lakey JR, McCready T, Rajotte RV, Yatscoff RW, Kneteman NM. Shapiro AM, et al. Among authors: yatscoff rw. Ther Drug Monit. 2005 Feb;27(1):35-7. doi: 10.1097/00007691-200502000-00008. Ther Drug Monit. 2005. PMID: 15665744
ISATX247: a novel calcineurin inhibitor.
Abel MD, Aspeslet LJ, Freitag DG, Naicker S, Trepanier DJ, Kneteman NM, Foster RT, Yatscoff RW. Abel MD, et al. Among authors: yatscoff rw. J Heart Lung Transplant. 2001 Feb;20(2):161. doi: 10.1016/s1053-2498(00)00290-4. J Heart Lung Transplant. 2001. PMID: 11250240 No abstract available.
137 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page